The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.
The U.S. Food and Drug Administration has declined to approve Milestone Pharmaceuticals' nasal spray to treat a type of heart ...
Stock analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of Rhythm Pharmaceuticals in ...
Rhythm Heaven is back! Get a new look at the new entry Rhythm Heaven: Groove in this gameplay trailer. Rhythm Heaven: Groove ...
Rhythm Heaven is back! Get a new look at the new entry Rhythm Heaven: Groove in this gameplay trailer. Rhythm Heaven: Groove ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Soleno Therapeutics (SLNO – Research Report) and ...
The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vera Therapeutics (VERA – Research Report), ...
Investment analysts at HC Wainwright issued their Q2 2026 earnings per share estimates for shares of Rhythm Pharmaceuticals in a research note issued on Monday, March 24th. HC Wainwright analyst R.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $69.89, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results